Comirnaty | Indications/Uses

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Indications/Uses

Comirnaty JN.1 (3 micrograms)/dose concentrate for dispersion for injection or (10 or 30 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in infants and children aged 6 months to 4 years (3 mcg), children 5 to 11 years (10 mcg) and individuals 12 years of age and older (30 mcg).

Comirnaty Indications/Uses

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma